<code id='51680113CE'></code><style id='51680113CE'></style>
      • <acronym id='51680113CE'></acronym>
      <center id='51680113CE'><center id='51680113CE'><tfoot id='51680113CE'></tfoot></center><abbr id='51680113CE'><dir id='51680113CE'><tfoot id='51680113CE'></tfoot><noframes id='51680113CE'>
      • <optgroup id='51680113CE'><strike id='51680113CE'><sup id='51680113CE'></sup></strike><code id='51680113CE'></code></optgroup>
        5. <b id='51680113CE'><label id='51680113CE'><select id='51680113CE'><dt id='51680113CE'><span id='51680113CE'></span></dt></select></label></b><u id='51680113CE'></u>
          <i id='51680113CE'><strike id='51680113CE'><tt id='51680113CE'><pre id='51680113CE'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / comprehensive      
           
     
           
      
          comprehensive 
           
      
           
      
           
       2025-10-03 00:13:53 
   
      
           
      
           
                        
          comprehensive  
          
                                   
                 
                                      author：explore   
                                        
                                      
                                      Page View：57
                                  
                                    
          
                                   
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images
          Is this the end of the line for the “pharma bro” with the perpetual smirk?
          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.
          advertisement
          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          FDA panel endorses Alnylam’s heart drug — after picking it apart
                                
                            
          Next article：  
                                      
                                          BioMarin wins approval for gene therapy to treat hemophilia A
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles